Resmed (RSMDF) Non Operating Income (2009 - 2026)

Resmed has reported Non Operating Income for 18 years, with the latest figure at -$1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 83.99% year-over-year to -$1.4 million; the trailing twelve-month figure through Mar 2026 stood at -$14.0 million (up 78.73% YoY), and the FY2025 full-year result was -$7.8 million, up 85.85% from the prior year.
• Non Operating Income for Q1 2026 stood at -$1.4 million, up from -$5.3 million in the prior quarter.
• The five-year high for Non Operating Income was $2.5 million in Q2 2022, with the low at -$54.6 million in Q2 2024.
• Historically, Non Operating Income has averaged -$9.0 million across 5 years, with a median of -$3.8 million in 2024.
• Annual changes were most pronounced in 2022 — Non Operating Income jumped 373.01% — and 2023, when it slumped 1090.03%.
• Resmed's Non Operating Income stood at -$1.7 million in 2022, then sank by 816.23% to -$15.6 million in 2023, then jumped by 106.9% to $1.1 million in 2024, then sank by 589.53% to -$5.3 million in 2025, then surged by 74.01% to -$1.4 million in 2026.
• The last three Non Operating Income figures came in at -$1.4 million (Q1 2026), -$5.3 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.